| Investment Objective | |
| An open-ended equity linked savings scheme (ELSS) with the objective of long term growth of capital through a portfolio with a target Investment Objective allocation of 80% equity, 20% debt and money market securities. The Scheme does not guarantee/ indicate any returns. There is no assurance that the objective of the Scheme will be achieved. | |
| Fund Category: ELSS | |
![]() |
|
| Fund Snapshot | |
| Date of Allotment : Mar 29, 1996 | |
| Benchmark:Nifty 500 TRI | |
| Fund Manager - Mr. Dhaval Shah Managing the Fund Since: November 01, 2024 Experience in Managing the Fund: 1.6 Years |
|
| SIP: Monthly: Minimum ₹ 500/- and in multiples of ₹ 500/- thereafter |
|
| Application Amount for fresh subscription: ₹ 500 (plus in multiplies of ₹ 1) |
|
| Minimum Additional Investment: ₹ 500 (plus in multiplies of ₹ 1) |
|
| Load Structure (as % of NAV) (Incl. for SIP) | |
| Entry Load: | NIL |
| Exit Load: | NIL |
| Count of Securities: 62 | |
| AUM as on May 31, 2026 (in ₹Crore) | |
| Month End AUM | 14,249.20 |
| Monthly Average AUM | 14,340.78 |
| Base Expense Ratio (BER) | |
| Regular | 1.46% |
| Direct | 0.83% |
| BER excludes brokerage incurred towards execution of trades, transaction cost & statutory levies as applicable to investors. | |
| NAV as on May 29, 2026 | |
| Regular Growth | 59.69 |
| Regular IDCW$ | 183.12 |
| Direct Growth | 67.03 |
| Direct IDCW$ | 421.26 |
| $Income Distribution cum capital withdrawal | |
| Valuation Parameters | |
| Average P/E | 24.88 |
| Average P/BV | 5.34 |
| Average Dividend Yield | 1.03% |
| Top 10 Sectoral Contribution (in %) |
![]() |
| Market Capitalisation |
![]() |
| Volatility Measures | |
| Portfolio Turnover | 0.26 |
| Standard Deviation | 14.65% |
| Sharpe Ratio | 0.54 |
| Beta | 0.93 |
| Treynor Ratio | 0.09 |
Note: Standard Deviation, Sharpe Ratio & Beta are calculated on Annualised basis using 3 years history of monthly returns. Risk FreeRate assumed tobe 5.52%(FBIL OvernightMIBOR as on 29 May, 2026) for calculating SharpeRatio
| Rating Profile of Portfolio | ![]() |
| Sector/Issuer Name | % of Total AUM |
% of Derivatives |
% of Net AUM |
| Equity & Equity Related | |||
| Banks | 23.41% | ||
| ICICI Bank Limited | 6.83% | ||
| HDFC Bank Limited | 6.30% | ||
| Axis Bank Limited | 4.07% | ||
| State Bank of India | 3.72% | ||
| The Federal Bank Limited | 2.49% | ||
| Finance | 8.25% | ||
| TVS HOLDINGS LIMTED | 2.10% | ||
| Bajaj Finance Limited | 1.64% | ||
| Cholamandalam Investment and Finance Company Limited | 1.45% | ||
| SBFC Finance Ltd | 1.28% | ||
| L&T Finance Limited | 1.04% | ||
| Home First Finance Company India Limited | 0.73% | ||
| IT - Software | 7.35% | ||
| Infosys Limited | 4.14% | ||
| Tech Mahindra Limited | 2.40% | ||
| Persistent Systems Limited | 0.81% | ||
| Retailing | 5.15% | ||
| Eternal Limited | 2.29% | ||
| Avenue Supermarts Limited | 1.35% | ||
| MEESHO LTD | 1.21% | ||
| Urban Co Ltd | 0.30% | ||
| Pharmaceuticals & Biotechnology | 4.75% | ||
| Sun Pharmaceutical Industries Limited | 2.16% | ||
| Emcure Pharmaceuticals Ltd | 1.61% | ||
| SAI Life Sciences Ltd | 0.56% | ||
| Biocon Limited | 0.38% | ||
| GlaxoSmithKline Pharmaceuticals Limited | 0.04% | ||
| Petroleum Products | 3.95% | ||
| Reliance Industries Limited | 3.95% | ||
| Healthcare Services | 3.46% | ||
| Fortis Healthcare Limited | 1.95% | ||
| Thyrocare Technologies Limited | 1.19% | ||
| Suraksha Diagnostic Ltd | 0.33% | ||
| Power | 3.34% | ||
| Adani Power Limited | 1.80% | ||
| NTPC Limited | 1.54% | ||
| Consumer Durables | 3.16% | ||
| Titan Company Limited | 1.35% | ||
| Dixon Technologies (India) Limited | 0.99% | ||
| L G Electronics India Ltd | 0.37% | ||
| Whirlpool of India Limited | 0.33% | ||
| V-Guard Industries Limited | 0.14% | ||
| Transport Infrastructure | 3.16% | ||
| Adani Ports and Special Economic Zone Limited | 3.16% | ||
| Personal Products | 3.12% | ||
| Godrej Consumer Products Limited | 1.79% | ||
| Gillette India Limited | 1.33% | ||
| Industrial Products | 3.01% | ||
| Cummins India Limited | 2.47% | ||
| Kirloskar Pneumatic Co Ltd | 0.54% | ||
| Insurance | 2.83% | ||
| Max Financial Services Limited | 1.11% | ||
| Medi Assist Healthcare Services Ltd | 0.93% | ||
| Go Digit General Insurance Ltd | 0.79% | ||
| Telecom - Services | 2.77% | ||
| Bharti Airtel Limited | 2.77% | ||
| Non - Ferrous Metals | 2.63% | ||
| Hindalco Industries Limited | 2.63% | ||
| Automobiles | 2.53% | ||
| Mahindra & Mahindra Limited | 2.53% | ||
| Capital Markets | 2.38% | ||
| Computer Age Management Services Limited | 1.67% | ||
| Nippon Life India Asset Management Limited | 0.70% | ||
| Beverages | 2.16% | ||
| Varun Beverages Limited | 2.16% | ||
| United Breweries (Holdings) Limited | 0.00% | ||
| Construction | 2.04% | ||
| Larsen & Toubro Limited | 2.04% | ||
| Cement & Cement Products | 1.61% | ||
| Ambuja Cements Limited | 1.39% | ||
| UltraTech Cement Limited | 0.23% | ||
| Realty | 1.42% | ||
| Aditya Birla Real Estate Ltd. | 0.88% | ||
| Prestige Estates Projects Limited | 0.54% | ||
| Leisure Services | 1.33% | ||
| Thomas Cook (India) Limited | 0.74% | ||
| Chalet Hotels Limited | 0.59% | ||
| Auto Components | 1.21% | ||
| ZF Commercial Vehicle Control Systems India Limited | 1.21% | ||
| Fertilizers & Agrochemicals | 1.10% | ||
| Sumitomo Chemical India Limited | 1.10% | ||
| Diversified FMCG | 0.96% | ||
| Hindustan Unilever Limited | 0.96% | ||
| Agricultural Food & other Products | 0.91% | ||
| Balrampur Chini Mills Limited | 0.91% | ||
| Chemicals & Petrochemicals | 0.71% | ||
| Vinati Organics Limited | 0.71% | ||
| Miscellaneous | 0.00% | ||
| Magnasound (I) Limited | 0.00% | ||
| Cash & Current Assets | 1.31% | ||
| Grand Total | 100.00% |
Miscellaneous includes securities with exposure of less than 0.01%
| Product Label | |
| Scheme Name | |
| Aditya Birla Sun Life ELSS Tax Saver Fund An Open ended Equity Linked Saving Scheme with a statutory lock-in of 3 years and tax benefit |
|
| This product is suitable for investors who are seeking*: | |
|
|
Risk-o-meter ![]() |
Benchmark Risk-o-meter Nifty 500 TRI ![]() |
| *Investors should consult their financial advisors if in doubt whether the product is suitable for them. | |